Intensive gliclazide regimen has long-lasting benefits

Australian researchers have discovered that intensive glucose control in patients with type 2 diabetes leads to reductions in kidney failure many years after return to usual care.

Their global study shows reduced renal failure risk five and a half years after patients with type 2 diabetes ended an intensive glucose lowering regimen based on gliclazide MR.

They report a reduced need for dialysis or transplantation without any change to the risks of death or